- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-08-01-2016
Pharmaceutical Executive
Pharm Exec's 15th Annual Industry Audit
August 31, 2016
Features
36
8
As market headwinds persist, our latest industry review of shareholder value reveals a sharp performance differential between companies that pursue a strategy of specialized therapeutic focus and those that continue to rely on line diversity, size and scale.
The Industry Audit: Fifteen Years Right
August 29, 2016
From the Editor
36
8
With our annual Industry Audit marking its 15th year, we decided to compare 2002 approaches in boosting shareholder value to those of today. The fall in one particular performance metric is telling.
Dealmaking in 2016: It’s Complicated
August 25, 2016
Features
36
8
Pharm Exec convenes some of the industry’s top business development professionals and negotiators to talk about the current climate for biophamara dealmaking and the critical job of appraising new assets and their potential as market-worthy and transformative products for patients.
Steady Hands: AmerisourceBergen's Peyton Howell
August 15, 2016
Features
36
8
Pharm Exec sits down with AmerisourceBergen supply chain leader Peyton Howell to discuss the latest trends in pharmaceutical distribution, including company efforts to boost efficiency, reliability, and enhance its groundbreaking partnership with Walgreens Boots Alliance.
Drug Shortages Raise Economic and Ethical Challenges
August 12, 2016
Columns
36
8
Analysts examine investment and business factors that shape supply disruptions.
The ‘Cure’-All for 21st Century Data Sharing
August 11, 2016
Columns
36
8
Balancing today’s health data demands and patient privacy is not about new regulations-it’s taking a risk-based approach.
On and Off the Pharma Podium
August 10, 2016
Columns
36
8
In the spirit of the Olympics, we cite some of the feel-good and not-so-good stories making waves in the competitive world of pharma.
European Pharma and the Unified Patent Court
August 01, 2016
Columns
36
8
A look at the EU plans for a European patent, and where the UK fits in the mix.
An EU Referendum ... on Drug Pricing?
August 01, 2016
Columns
36
8
The chances are slim, but a new resolution in Europe on the subject could drum up support for a Brexit-like scenario.
Country Report: Hungary
August 01, 2016
Special Sponsored Section
36
8
Although Hungary has posted the third-highest economic growth rate in the EU since 2014, its healthcare system is struggling-dictating the need for new efforts if the country is to regain its dominance as a central and eastern European-region trailblazer in the life sciences.
Pharmaceutical Executive, August 2016 Issue (PDF)
August 01, 2016
Issue PDF
36
8
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.